“pfizer” Archives

in
Entry Author Date Location
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
Bristol Myers to Buy MyoKardia, FDA-Ready Heart Disease Drug for $13.1B 10/05/20 New York
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
FDA Lifts Solid Bio Clinical Hold, Duchenne Study Cleared to Resume 10/01/20 Boston
Pfizer Pumps $200M Into CStone for Rights to PD-L1 Cancer Drug in China 09/30/20 New York
Monte Rosa Raises $96M for “Glue-Based” Protein Degrading Drugs 09/24/20 Boston
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue 09/09/20 National
Akcea Therapeutics Is Returning to Parent Ionis Pharma in $500M Buyout 08/31/20 Boston
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Bio Roundup: J&J Buyout, BioMarin Rebuffed, Poseida on Hold & More 08/21/20 National
Alzheon Lands $47M to Take Another Shot at a Pivotal Alzheimer’s Test 08/20/20 Boston
FDA Rejects BioMarin Hemophilia Gene Therapy, Asks for More Data 08/19/20 National
CureVac’s IPO Hauls In $213M as Key mRNA COVID-19 Vaccine Test Nears 08/14/20 Europe
Pfizer’s Bourla: There’s Coronavirus Vaccine Pressure, But It’s Not Political 08/12/20 National
Moderna, Pfizer Protocols May Make COVID Vaccines Hard to Compare 08/07/20 National
Kymera Therapeutics Unveils IPO Pitch for Protein Degradation 07/31/20 Boston
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
Pfizer, BioNTech Choose Full Spike Protein for Pivotal Vaccine Test 07/28/20 New York
Bio Roundup: Jazz Drug OK’d, Gilead’s Bet, Moderna Patent Decision & More 07/24/20 National
Moderna Publishes Early COVID-19 Vaccine Data, Preps for Phase 3 Test 07/15/20 Boston
Bio Roundup: Blackstone’s Billions, Biogen Finishes Filing, Novavax at “Warp Speed” & More 07/10/20 National
CSL Behring Bolsters Hemophilia Lineup With Deal for uniQure’s Gene Therapy 06/25/20 Philadelphia
Reneo Readies for Global Test of Drug for Rare Mitochondrial Disease 06/23/20 San Diego
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Moderna Finalizes Plan, Dose for Phase 3 Test of mRNA COVID Vaccine 06/11/20 Boston
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Regeneron Pays Intellia $100M to Add Hemophilia to CRISPR R&D Pact 06/01/20 New York
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Page 1 of 33 next page »